Literature DB >> 8376355

A 50-kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells.

M A Schwartz1, E J Brown, B Fazeli.   

Abstract

A 50-kDa integrin-associated protein (IAP), identified by its role in activation of neutrophils by extracellular matrix proteins, has recently been found to have a primary sequence that predicts five transmembrane domains, raising the possibility that the protein participates in ion transport. In endothelial cells, extracellular matrix proteins and anti-integrin antibodies have been shown to trigger an influx of [Ca2+]i via voltage-independent membrane channels. We now show that monoclonal antibodies to IAP that block neutrophil activation completely inhibited the fibronectin-stimulated rise in [Ca2+]i in endothelial cells. An antibody that binds IAP but does not block neutrophil function had no effect on endothelial cell [Ca2+]i. Inhibition of IAP function had no effect on endothelial cell adhesion, no effect on the integrin-mediated rise in intracellular pH, and no effect on the integrin-mediated increase in tyrosine phosphorylation. In addition, inhibition of IAP had no effect on the influx of Ca2+ triggered by histamine. These results demonstrate that IAP is specifically required for the integrin-regulated calcium influx and suggest that IAP itself might be an integrin-associated calcium channel.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376355

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Contemplating the plasmalemmal control center model.

Authors:  B G Pickard
Journal:  Protoplasma       Date:  1994       Impact factor: 3.356

Review 2.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

3.  Acoustic tweezers for studying intracellular calcium signaling in SKBR-3 human breast cancer cells.

Authors:  Jae Youn Hwang; Chi Woo Yoon; Hae Gyun Lim; Jin Man Park; Sangpil Yoon; Jungwoo Lee; K Kirk Shung
Journal:  Ultrasonics       Date:  2015-06-26       Impact factor: 2.890

4.  Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins).

Authors:  F Berditchevski; M M Zutter; M E Hemler
Journal:  Mol Biol Cell       Date:  1996-02       Impact factor: 4.138

5.  Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.

Authors:  Saumya Ramanathan; Stacy Mazzalupo; Scott Boitano; William R Montfort
Journal:  Biochemistry       Date:  2011-08-16       Impact factor: 3.162

6.  Alphav integrins mediate adhesion and migration of breast carcinoma cell lines.

Authors:  N C Wong; B M Mueller; C F Barbas; P Ruminski; V Quaranta; E C Lin; J W Smith
Journal:  Clin Exp Metastasis       Date:  1998-01       Impact factor: 5.150

7.  The Arg-Gly-Asp motif in the cell adhesion molecule L1 promotes neurite outgrowth via interaction with the alphavbeta3 integrin.

Authors:  P M Yip; X Zhao; A M Montgomery; C H Siu
Journal:  Mol Biol Cell       Date:  1998-02       Impact factor: 4.138

8.  Attenuation of pressure-induced myogenic contraction and tyrosine phosphorylation by fasudil, a cerebral vasodilator, in rat cerebral artery.

Authors:  N Masumoto; Y Tanabe; M Saito; K Nakayama
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

9.  Impaired memory retention and decreased long-term potentiation in integrin-associated protein-deficient mice.

Authors:  H P Chang; F P Lindberg; H L Wang; A M Huang; E H Lee
Journal:  Learn Mem       Date:  1999 Sep-Oct       Impact factor: 2.460

10.  Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases.

Authors:  D D Schlaepfer; T Hunter
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.